| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.5 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |